Drug Development Life Science Training 
Healthcare IT Today
JANUARY 23, 2024
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
Healthcare IT News - Telehealth
JANUARY 20, 2022
That is the opinion of Ron Emerson, RN, global healthcare lead at Zoom, as he looks ahead at what he believes will be some developments in healthcare in 2022. Virtual tools also facilitate access to medical training, as healthcare providers now can seek expert guidance from the other side of the globe at the touch of a button.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
JANUARY 7, 2025
.” To drive impact with your AI initiatives, you must have a clear idea of what your organization is trying to achieve, what part of that goal is best suited for automation, and then select a solution with the training required to do what you are asking of them with a high degree of accuracy and reliability.
Lloyd Price
NOVEMBER 16, 2024
The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services. MarketScan University: Offers educational resources and training programs.
Digital Health Global
AUGUST 30, 2023
QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.
Digital Health Global
SEPTEMBER 28, 2023
“We are excited to partner with Debiopharm and redefine the landscape of clinical development with AI,” said Livia Lifes, co-founder and CEO at Neuroute. The fund has already started its activity with two Seed investments, with two more to be announced soon.
Digital Health Global
APRIL 10, 2023
Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.
Expert insights. Personalized for you.
122 
Let's personalize your content